Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacLachlan, L. K.
Right arrow Articles by Smith, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacLachlan, L. K.
Right arrow Articles by Smith, S. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 265, Issue 17, 9764-9770, 06, 1990

Binding of a calcium sensitizer, bepridil, to cardiac troponin C. A fluorescence stopped-flow kinetic, circular dichroism, and proton nuclear magnetic resonance study

LK MacLachlan, DG Reid, RC Mitchell, CJ Salter and SJ Smith
Department of Physical Organic Chemistry, Smith Kline & French Research Ltd., Welwyn, Hertfordshire, United Kingdom.

Stopped-flow fluorescence kinetic measurements, circular dichroism (CD), and 1H nuclear magnetic resonance (NMR) spectroscopy at 360 MHz have been used to study the interaction of the calcium-channel blocker and calmodulin antagonist bepridil with cardiac troponin C (cTnC) in the presence of calcium. The kinetic data show that bepridil reduces the rate of calcium release only from the low affinity, calcium- specific site and not from the two high affinity calcium/magnesium sites. CD measurements indicate that drug binding leads to a small increase in the alpha-helical content of the complex. 1H NMR shows that the protein binds one equivalent of bepridil, with a dissociation constant of approximately 20 microM, only when the low affinity calcium site is occupied. Exchange is fast or intermediate on the chemical shift time scale. Drug binding is shown to be largely localized in the N-terminal domain, containing the low affinity calcium site, by observing the shifting and broadening of several resonances associated with that domain. These include assigned aromatic signals together with methionyl and other methyl signals. Observation of intermolecular nuclear Overhauser effects was precluded by extensive spectral overlap. Consideration of the data from the three techniques permitted a model of the bepridil-cTnC complex to be constructed, using the model of cTnC derived from the x-ray structure of calmodulin (MacLachlan L. K., Reid, D. G., and Carter, N. (1990) J. Biol. Chem. 265, 9754-9763). Binding of bepridil to a prominent hydrophobic depression in the N-terminal domain can be invoked to explain many of the induced changes in the spectral and kinetic properties of the protein. The implications of the model for the calcium sensitizing action of bepridil are discussed.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Physiol.Home page
K. L. Kreutziger, N. Piroddi, B. Scellini, C. Tesi, C. Poggesi, and M. Regnier
Thin filament Ca2+ binding properties and regulatory unit interactions alter kinetics of tension development and relaxation in rabbit skeletal muscle
J. Physiol., August 1, 2008; 586(15): 3683 - 3700.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. P. Davis and S. B. Tikunova
Ca2+ exchange with troponin C and cardiac muscle dynamics
Cardiovasc Res, March 1, 2008; 77(4): 619 - 626.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. V. Vinogradova, D. B. Stone, G. G. Malanina, C. Karatzaferi, R. Cooke, R. A. Mendelson, and R. J. Fletterick
Ca2+-regulated structural changes in troponin
PNAS, April 5, 2005; 102(14): 5038 - 5043.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W.-J. Dong, J. M. Robinson, J. Xing, and H. C. Cheung
Kinetics of Conformational Transitions in Cardiac Troponin Induced by Ca2+ Dissociation Determined by Forster Resonance Energy Transfer
J. Biol. Chem., October 24, 2003; 278(43): 42394 - 42402.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Buscemi, D. B. Foster, I. Neverova, and J. E. Van Eyk
p21-Activated Kinase Increases the Calcium Sensitivity of Rat Triton-Skinned Cardiac Muscle Fiber Bundles via a Mechanism Potentially Involving Novel Phosphorylation of Troponin I
Circ. Res., September 20, 2002; 91(6): 509 - 516.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Wang, M. X. Li, and B. D. Sykes
Structure of the Regulatory N-domain of Human Cardiac Troponin C in Complex with Human Cardiac Troponin I147-163 and Bepridil
J. Biol. Chem., August 16, 2002; 277(34): 31124 - 31133.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. Kischel, B. Bastide, L. Stevens, and Y. Mounier
Expression and functional behavior of troponin C in soleus muscle fibers of rat after hindlimb unloading
J Appl Physiol, March 1, 2001; 90(3): 1095 - 1101.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Kleerekoper and J. A. Putkey
Drug Binding to Cardiac Troponin C
J. Biol. Chem., August 20, 1999; 274(34): 23932 - 23939.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Paakkonen, A. Annila, T. Sorsa, P. Pollesello, C. Tilgmann, I. Kilpelainen, P. Karisola, I. Ulmanen, and T. Drakenberg
Solution Structure and Main Chain Dynamics of the Regulatory Domain (Residues 1-91) of Human Cardiac Troponin C
J. Biol. Chem., June 19, 1998; 273(25): 15633 - 15638.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Kleerekoper, W. Liu, D. Choi, and J. A. Putkey
Identification of Binding Sites for Bepridil and Trifluoperazine on Cardiac Troponin C
J. Biol. Chem., April 3, 1998; 273(14): 8153 - 8160.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W.-J. Dong, C.-K. Wang, A. M. Gordon, S. S. Rosenfeld, and H. C. Cheung
A Kinetic Model for the Binding of Ca2+ to the Regulatory Site of Troponin from Cardiac Muscle
J. Biol. Chem., August 1, 1997; 272(31): 19229 - 19235.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B.-S. Pan and R. G. Johnson Jr.
Interaction of Cardiotonic Thiadiazinone Derivatives with Cardiac Troponin C
J. Biol. Chem., January 12, 1996; 271(2): 817 - 823.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Lin, D. G. Dotson, and J. A. Putkey
Covalent Binding of Peptides to the N-terminal Hydrophobic Region of Cardiac Troponin C Has Limited Effects on Function
J. Biol. Chem., January 5, 1996; 271(1): 244 - 249.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Li, M. L. Love, J. A. Putkey, and C. Cohen
Bepridil opens the regulatory N-terminal lobe of cardiac troponin C
PNAS, May 9, 2000; 97(10): 5140 - 5145.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1990 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement